ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-OR064

A Pivotal Role of WNK1/OSR1 Pathway in Regulation of Renal Proximal Sodium Transport

Session Information

Category: Fluid and Electrolytes

  • 901 Fluid and Electrolytes: Basic


  • Nakamura, Motonobu, The University of Tokyo, Tokyo, Japan
  • Horita, Shoko, The University of Tokyo, Tokyo, Japan
  • Satoh, Nobuhiko, The University of Tokyo, Tokyo, Japan
  • Seki, George, Yaizu City Hospital, Yaizu, Japan
  • Mizuno, Tomohito, The University of Tokyo, Tokyo, Japan
  • Tsukada, Hiroyuki, The University of Tokyo, Tokyo, Japan
  • Sato, Yusuke, The University of Tokyo Hospital, Tokyo, Japan
  • Kume, Haruki, The University of Tokyo Hospital, Tokyo, Japan
  • Nangaku, Masaomi, The University of Tokyo, Tokyo, Japan
  • Suzuki, Masashi, Tokyo Gakugei University, Koganei, Tokyo, TOKYO, Japan

In renal proximal tubules (PTs) we and others have shown that insulin stimulates both apical Na+/H+ exchanger (NHE)3 and basolateral Na+/HCO3- co-transporter (NBCe1) via PI3K/Akt signaling. Pioglitazone (Pio) also stimulates both NHE3 and NBCe1 via non-genomic PPARg/ERK signaling (Cell Metab 2011). In human PTs, angiotensin (Ang)II stimulates both transporters via NO/ERK signaling (JASN 2014). However, the mechanism underlying this coordinate regulation in apical and basolateral PT sodium transport is poorly understood. In this study, we investigated the role of WNK1/OSR1 pathway in regulation of PT sodium transport.


By using a pH-sensitive dye BCECF we measured the basolateral NBCe1 activity and apical NHE3 activity in freshly-isolated rat PTs as well as human PTs, the latter obtained during surgery for renal cell carcinoma. We also measured the NBCe1 activity in rat PTs incubated overnight with siRNA against WNK1, WNK3, OSR1 or SPAK. Protein phosphorylation was analyzed by Western blotting in rat and human kidney cortex tissue.


In freshly-isolated rat and human PTs, insulin and Pio markedly stimulated both NHE3 and NBCe1 activities, and an OSR1/SPAK inhibitor, Closantel (10mM) completely suppressed these stimulatory effects. Closantel also completely suppressed the AngII-stimulated NBCe1 and NHE3 activities in human PTs. Immunostaining analysis confirmed the expression of OSR1 protein in rat and human PTs. In rat and human kidney cortex, Closantel suppressed the insulin-induced OSR1/SPAK phosphorylation without affecting the Akt phosphorylation. Similarly, Closantel suppressed the OSR1/SPAK phosphorylation by Pio and AngII without affecting the ERK phosphorylation. In overnight incubated rat PTs, siRNA against WNK1 but not WNK3 abolished the stimulatory effects of Pio and insulin on NBCe1. Moreover, siRNA against OSR1 but not SPAK abolished the stimulatory effects of Pio and insulin.


These results indicate, for the first time to our knowledge, that diverse stimuli depending on the distinct signaling cascades converge into WNK1/OSR1 pathway, which may work as a master regulator of PT sodium transport and hence represent a novel therapeutic target in hypertension and/or volume expansion.


  • Government Support - Non-U.S.